Dechra Pharmaceuticals PLC

LSE:DPH Rapport sur les actions

Capitalisation boursière : UK£4.4b

Dechra Pharmaceuticals Croissance future

Future contrôle des critères 4/6

Dechra Pharmaceuticals devrait augmenter ses bénéfices et son chiffre d'affaires de 62.5% et de 7.9% par an respectivement. Le BPA devrait croître de de 89.8% par an. Le rendement des capitaux propres devrait être 19.8% dans 3 ans.

Informations clés

62.5%

Taux de croissance des bénéfices

89.8%

Taux de croissance du BPA

Pharmaceuticals croissance des bénéfices19.6%
Taux de croissance des recettes7.9%
Rendement futur des capitaux propres19.8%
Couverture par les analystes

Low

Dernière mise à jour03 Jan 2024

Mises à jour récentes de la croissance future

Recent updates

Dechra Pharmaceuticals (LON:DPH) Takes On Some Risk With Its Use Of Debt

May 31
Dechra Pharmaceuticals (LON:DPH) Takes On Some Risk With Its Use Of Debt

A Look At The Intrinsic Value Of Dechra Pharmaceuticals PLC (LON:DPH)

Mar 28
A Look At The Intrinsic Value Of Dechra Pharmaceuticals PLC (LON:DPH)

We Think Dechra Pharmaceuticals (LON:DPH) Is Taking Some Risk With Its Debt

Mar 02
We Think Dechra Pharmaceuticals (LON:DPH) Is Taking Some Risk With Its Debt

Dechra Pharmaceuticals' (LON:DPH) Dividend Will Be Increased To £0.125

Mar 02
Dechra Pharmaceuticals' (LON:DPH) Dividend Will Be Increased To £0.125

Estimating The Intrinsic Value Of Dechra Pharmaceuticals PLC (LON:DPH)

Dec 09
Estimating The Intrinsic Value Of Dechra Pharmaceuticals PLC (LON:DPH)

Dechra Pharmaceuticals (LON:DPH) Is Increasing Its Dividend To £0.3289

Oct 06
Dechra Pharmaceuticals (LON:DPH) Is Increasing Its Dividend To £0.3289

Dechra Pharmaceuticals (LON:DPH) Is Paying Out A Larger Dividend Than Last Year

Sep 22
Dechra Pharmaceuticals (LON:DPH) Is Paying Out A Larger Dividend Than Last Year

Dechra Pharmaceuticals (LON:DPH) Will Pay A Larger Dividend Than Last Year At £0.3289

Sep 08
Dechra Pharmaceuticals (LON:DPH) Will Pay A Larger Dividend Than Last Year At £0.3289

Estimating The Intrinsic Value Of Dechra Pharmaceuticals PLC (LON:DPH)

Aug 18
Estimating The Intrinsic Value Of Dechra Pharmaceuticals PLC (LON:DPH)

Do Dechra Pharmaceuticals' (LON:DPH) Earnings Warrant Your Attention?

Aug 02
Do Dechra Pharmaceuticals' (LON:DPH) Earnings Warrant Your Attention?

These 4 Measures Indicate That Dechra Pharmaceuticals (LON:DPH) Is Using Debt Reasonably Well

Jun 10
These 4 Measures Indicate That Dechra Pharmaceuticals (LON:DPH) Is Using Debt Reasonably Well

Calculating The Fair Value Of Dechra Pharmaceuticals PLC (LON:DPH)

May 08
Calculating The Fair Value Of Dechra Pharmaceuticals PLC (LON:DPH)

Do Dechra Pharmaceuticals's (LON:DPH) Earnings Warrant Your Attention?

Apr 22
Do Dechra Pharmaceuticals's (LON:DPH) Earnings Warrant Your Attention?

Dechra Pharmaceuticals (LON:DPH) Is Increasing Its Dividend To UK£0.12

Feb 23
Dechra Pharmaceuticals (LON:DPH) Is Increasing Its Dividend To UK£0.12

Is Dechra Pharmaceuticals PLC (LON:DPH) Expensive For A Reason? A Look At Its Intrinsic Value

Jan 29
Is Dechra Pharmaceuticals PLC (LON:DPH) Expensive For A Reason? A Look At Its Intrinsic Value

Is Now The Time To Put Dechra Pharmaceuticals (LON:DPH) On Your Watchlist?

Jan 11
Is Now The Time To Put Dechra Pharmaceuticals (LON:DPH) On Your Watchlist?

Here's Why Dechra Pharmaceuticals (LON:DPH) Can Manage Its Debt Responsibly

Dec 04
Here's Why Dechra Pharmaceuticals (LON:DPH) Can Manage Its Debt Responsibly

It Looks Like Shareholders Would Probably Approve Dechra Pharmaceuticals PLC's (LON:DPH) CEO Compensation Package

Oct 15
It Looks Like Shareholders Would Probably Approve Dechra Pharmaceuticals PLC's (LON:DPH) CEO Compensation Package

Dechra Pharmaceuticals' (LON:DPH) Upcoming Dividend Will Be Larger Than Last Year's

Sep 25
Dechra Pharmaceuticals' (LON:DPH) Upcoming Dividend Will Be Larger Than Last Year's

Dechra Pharmaceuticals (LON:DPH) Will Pay A Larger Dividend Than Last Year At UK£0.29

Sep 11
Dechra Pharmaceuticals (LON:DPH) Will Pay A Larger Dividend Than Last Year At UK£0.29

With EPS Growth And More, Dechra Pharmaceuticals (LON:DPH) Is Interesting

Sep 08
With EPS Growth And More, Dechra Pharmaceuticals (LON:DPH) Is Interesting

Is Dechra Pharmaceuticals PLC (LON:DPH) Worth UK£43.4 Based On Its Intrinsic Value?

Jun 17
Is Dechra Pharmaceuticals PLC (LON:DPH) Worth UK£43.4 Based On Its Intrinsic Value?

Is Dechra Pharmaceuticals PLC (LON:DPH) A Smart Choice For Dividend Investors?

Apr 09
Is Dechra Pharmaceuticals PLC (LON:DPH) A Smart Choice For Dividend Investors?

Dechra Pharmaceuticals (LON:DPH) Has A Pretty Healthy Balance Sheet

Mar 05
Dechra Pharmaceuticals (LON:DPH) Has A Pretty Healthy Balance Sheet

Are Dechra Pharmaceuticals' (LON:DPH) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Feb 17
Are Dechra Pharmaceuticals' (LON:DPH) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Dechra Pharmaceuticals PLC (LON:DPH) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?

Feb 02
Dechra Pharmaceuticals PLC (LON:DPH) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?

Prévisions de croissance des bénéfices et des revenus

LSE:DPH - Estimations futures des analystes et données financières antérieures (GBP Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
6/30/2026954187N/AN/A1
6/30/20259041231601825
6/30/20248371021421632
6/30/2023762-283364N/A
3/31/202374463975N/A
12/31/2022727404586N/A
9/30/20227044945105N/A
6/30/20226825845123N/A
3/31/20226616648121N/A
12/31/20216417351119N/A
9/30/2021624643104N/A
6/30/202160856-4589N/A
3/31/202158750-45102N/A
12/31/202056644-44114N/A
9/30/2020541397110N/A
6/30/20205153457106N/A
3/31/2020507315791N/A
12/31/2019499295776N/A
9/30/2019490305879N/A
6/30/2019482315982N/A
3/31/2019463286182N/A
12/31/2018444256281N/A
9/30/2018426305773N/A
6/30/2018407365164N/A
3/31/2018394405769N/A
12/31/2017381436375N/A
9/30/2017370356576N/A
6/30/2017359266777N/A
3/31/201733419N/A69N/A
12/31/201630911N/A62N/A
9/30/201627812N/A53N/A
6/30/201624813N/A44N/A
3/31/201623017N/A43N/A
12/31/201521320N/A42N/A
9/30/201520820N/A42N/A
6/30/201520319N/A41N/A
3/31/201520121N/A41N/A
12/31/201419922N/A42N/A
9/30/201419621N/A27N/A
6/30/201419419N/A11N/A
12/31/201319314N/A25N/A
9/30/201319113N/A31N/A
6/30/201318911N/A37N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: DPH devrait devenir rentable au cours des 3 prochaines années, ce qui est considéré comme une croissance plus rapide que le taux d'épargne ( 1.5% ).

Bénéfices vs marché: DPH devrait devenir rentable au cours des 3 prochaines années, ce qui est considéré comme une croissance supérieure à la moyenne du marché.

Croissance élevée des bénéfices: DPH devrait devenir rentable dans les 3 prochaines années.

Chiffre d'affaires vs marché: Le chiffre d'affaires de DPH ( 7.9% par an) devrait croître plus rapidement que le marché UK ( 3.5% par an).

Croissance élevée des revenus: Le chiffre d'affaires de DPH ( 7.9% par an) devrait croître plus lentement que 20% par an.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Le retour sur capitaux propres de DPH devrait être faible dans 3 ans ( 19.8 %).

Découvrir les entreprises en croissance

7D

1Y

7D

1Y

7D

1Y